Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1Tourette Syndrome 1Tic Disorders 1Neurodevelopmental Disorders 1Fragile X Syndrome 1DiGeorge Syndrome 1Autistic Disorder 1Autism Spectrum Disorder 1Attention Deficit Disorder with Hyperactivity 1Anxiety Disorders 122q11 Deletion Syndrome 1

Interventions

Cognitive Behavioral Therapy 4Psilocybin 3Therapeutics 2Oxygen 2Music Therapy 2Methods 2Waiting Lists 1Transurethral Resection of Prostate 1Touch 1Thyroidectomy 1TEMPO 1Surveys and Questionnaires 1Standard of Care 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Respiration 1Referral and Consultation 1Psychotherapy 1Pharmaceutical Preparations 1Paramedics 1Palliative Care 1Niacin 1Midazolam 1Methylphenidate 1Melatonin 1Ketamine 1Injections 1Hypnosis 1Glutamyl Aminopeptidase 1Fluoxetine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anxiety Disorders × Sertraline × Clear all
NCT06081348 2025-07-16

CALM

Holland Bloorview Kids Rehabilitation Hospital

Phase 2 Recruiting
130 enrolled

Autism Spectrum Disorder, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, DiGeorge Syndrome, Fragile X Syndrome, Tourette Syndrome, Tic Disorders, Tuberous Sclerosis, 22q11 Deletion Syndrome, Neurodevelopmental Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡